3SBio Inc.

3SBio Inc. Announces Unaudited Third Quarter 2009 Results.
PR Newswire; 11/12/2009; 6473 words; ...China, Nov. 12 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. ("3SBio" or "the Company"), a leading China-based biotechnology...year. -- Dr. Jing Lou, chief executive officer of 3SBio, commented: "Overall, the business is performing...

SSRX, JMBA, ZIOP, GASS, ELRN, ADG Expected To Be Lower After Earnings Releases on Thursday.
M2 Presswire; 11/9/2009; 3195 words; ...Quarter Release Time SSRX 3SBio Inc. 12 quarters Q3 After JMBA...see if a pattern exists. 3SBio Inc. (NASDAQ: SSRX), a...other autoimmune diseases. 3SBio sells its products through...with AMAG Pharmaceuticals, Inc. for ferumoxytol. The...

3SBio Inc. Announces Results of Annual General Meeting.
Biotech Week; 11/4/2009; 559 words; 3SBio Inc. (NASDAQ:SSRX) ("3SBio" or "Company...shareholders held on October 12, 2009 (see also 3SBio Inc.). At the meeting, the Company's shareholders...year ending December 31, 2009. Keywords: 3SBio Inc., Biopharmaceuticals, Drugs, Therapies...

Orexigen Prices IPO To Raise $84M For Obesity Programs.
BIOWORLD Today; 11/3/2009; 1190 words; ...far this year, Orexigen Therapeutics Inc. priced 7 million shares at $12 apiece...That puts it behind Chinese firm 3SBio Inc.'s $115.2 million offering in...based Molecular Insight Pharmaceuticals Inc. (See BioWorld Today, Feb. 21...

News and FDA Updates for 3SBio (Nasdaq:SSRX), TomoTherapy (NASDAQ:TOMO).
M2 Presswire; 10/28/2009; 847 words; ...BiomedReports: News and FDA Updates for 3SBio (Nasdaq:SSRX), TomoTherapy (NASDAQ...BioMedReports.Com On 10/27/09, 3SBio Inc. (Nasdaq:SSRX), a leading China...2009. On 10/27/09, TomoTherapy Inc., (NASDAQ:TOMO) announced four...